Sanofi Ventures
Corporate VCCambridge · Seed–Late Stage · 26 people tracked
Investment thesis
Sanofi Ventures invests in top-tier biotech and digital health companies aiming to help patients and transform the practice of medicine. As Sanofi's strategic venture arm, it targets early-stage transformational science and technology when companies are too early to partner with or acquire. The firm invests across all stages of the private company lifecycle, from Seed through Series B and beyond, and is willing to lead financings, take board seats, and work closely with portfolio companies to build long-term value. Areas of focus include immunology, oncology, rare diseases, vaccines, and digital innovation, with a growing emphasis on artificial intelligence applied to healthcare and drug development.
Source: firm website, verified Aug 3, 2026.
Team · 26 people
from the firm's website & public directories
What they invest in
from 37 of 107 portfolio companiesBiotech ×26Healthtech ×18Medical Devices ×15Digital Health ×10AI & Machine Learning ×8Deep Tech ×5Data & Infrastructure ×1Defense Tech ×1
HQs:United States×23Switzerland×1Spain×1
Investments · 107 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12022 · 12021 · 12020 · 22016 · 18 dated
BiotechSan Diego, US
Amir Nashat(Director)John Mendlein(Director)Christian Weyer(Executive Officer, Director)William Rastetter(Director)J. Scott Wolchko(Executive Officer)Mark Enyedy(Director)
Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.
BiotechDeep TechHealthtech
MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients, including oncology, hematology, and autoimmune applications.
BiotechMedical Devices
Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
Jonathan Root(Director)Casper De Clercq(Director)Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)Sean Duffy(Executive Officer, Director)Balaji Srinivasan(Director)
Abcuro is a clinical-stage biopharmaceutical company developing ulviprubart, a monoclonal antibody that selectively depletes highly cytotoxic T cells by targeting the KLRG1 receptor.
BiotechHealthtechNewton, US
John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Ryan Berry(Director)Donald McCarthy(Director)John Edwards(Director)Yajun Xu(Director)
Board seatJason P. Hafler· per SEC Form D
Granite Bio develops first-in-class therapeutic antibodies targeting inflammation, autoimmunity, and fibrosis for patients lacking effective treatment options.
BiotechMedical DevicesBasel, CH
Patrick Loustau(President and Chief Executive Officer)
Lifordi Immunotherapeutics develops treatments for immunology and rare diseases through discovery, clinical development, and commercialization.
BiotechDeep TechHealthtech
Arthur O. Tzianabos, Ph.D.(President and CEO)Naina Bhasin, Ph.D.(Chief Business Officer)
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Frutos(Co-founder)Dr. Vila-Perelló(CEO)
AdvanCell develops radioisotope-based therapies, using Th-228 sourced through the U.S.
BiotechHealthtechMedical DevicesCambridge, US
Philina Lee(Executive Officer, Director)Aaron Pickett(Executive Officer)Wing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)Jamil Beg(Director)
Board seatChristopher Gagliardi· per SEC Form D
Click Therapeutics develops software-based prescription medical treatments for patients with unmet medical needs, combining neuroscience with digital technology to create a new treatment modality.
Digital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)Randall Stanicky(Executive Officer)Nicholas Schork(Director)Victor Gao(Director)Emile Westergaard(Director)
BoardAlex Zisson(Director)
Board seatCris De Luca· per SEC Form D
BiotechSan Diego, US
JeenJoo Kang(Director)Robert Tjian(Director)Alain Baron(Executive Officer, Director)Marcus Boehm(Executive Officer)Andrew Schwab(Director)
Board seatJason P. Hafler· per SEC Form D · $77.5M raise · filed Sep 2020
BiotechDel Mar, US
Paul Stone(Executive Officer)Yujiro Hata(Director)Kevin Forrest(Executive Officer, Director)Scott Rocklage(Executive Officer, Director)Matthew Disney(Director)Jason Hafler(Director)
Board seatJason P. Hafler· per SEC Form D · $5M raise · filed Jun 2017
Cambridge, US
Board seatJason P. Hafler· per SEC Form D · $70M raise · filed Oct 2022
South San Francisco, US
Board seatJason P. Hafler· per SEC Form D · $125M raise · filed Oct 2025
Attovia develops precision biologics using its ATTOBODY platform for patients with immune-mediated diseases.
BiotechDigital Health
Avilar develops protein degrader drugs targeting extracellular and membrane-bound proteins, using a novel class called ATACs that harness endolysosomal degradation machinery.
AI & Machine LearningBiotechMedical DevicesWaltham, US
THERESA CAMERON(Director)PAULINA HILL(Director)MARTIN FREED(Director)STEPHANIE TOZZO(Executive Officer)PHIL GRAHAM(Executive Officer)MILIND DESHPANDE(Director)
Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.
BiotechLongevityMedical Devices
David Meek(Chief Executive Officer)Brian Riley(President & Chief Technical Officer)Joanne Lager(Chief Medical Officer)Wendy DiCicco(Chief Financial Officer)Adrian Chaisson(Chief of Staff)Daniel S. Lynch(Director)
BranchLab is a healthcare AI company that builds predictive systems for regulated organizations in the healthcare sector, helping them make better decisions about patient outcomes and treatment commercialization while maintaining privacy and regulatory compliance.
AI & Machine LearningHealthtechNew York, US
Michael Parkes(Director)Joshua Walsh(Executive Officer, Director)Carrie Williams(Director)Christopher Cagle(Executive Officer, Director)
BoardAndrew Bouldin(Director)
Carbon Health operates a chain of clinics and a companion app offering primary, urgent, and virtual care visits, with same-day appointments, provider chat, and access to medical records.
Digital HealthHealthtech
Eren Bali(Founder)
HealthtechCambridge, US
Richard Whalley(Executive Officer, Director)Patrick Flynn(Director)James White(Executive Officer, Director)
Manhattan Beach, US
Peter Kim(Executive Officer, Director, Promoter)Francis Lam(Executive Officer, Director, Promoter)Bill Geary(Director)Mohamad Makhzoumi(Director)
Empatica develops software and algorithms that monitor neurological patients through wearable sensors, providing real-time physiological and behavioral biomarkers to patients, clinicians, and researchers.
AI & Machine LearningDigital HealthHealthtechMedical DevicesCambridge, US
Rosalind Picard(Founder and Director of the Affective Computing Group at the MIT Media Lab and Faculty Chair, MIT Mind+Hand+Heart Wellbeing Initiative)Matteo Lai(Executive Officer, Director)Mario Scuderi(Director)Simone Tognetti(Director)
Company measuring health in everyday life via a permissioned real-world data platform.
Evidation collects and analyzes real-world health data from millions of community members to enable clinical research and health programs across various medical conditions.
BiotechData & InfrastructureDigital HealthHealthtechSan Francisco, US
David Fleshman(Director)Rowan Chapman(Director)Christine Lemke(Executive Officer, Director)Deborah Kilpatrick(Executive Officer, Director)
Developing therapies for congenital disorders of glycosylation combining replacement therapies with intracellular delivery vehicles.
Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.
Biotech
Steven Axon(Chief Executive Officer)Hicham Alaoui(Chief Scientific Officer)Rose Marino(Chief Medical Officer)Peter McWilliams(Chief Business Officer)Geoffrey Hird(Chief Technology Officer)
Sebastian G. Schneeweiss(Director)William Geary(Director)Jeremy Rassen(Executive Officer, Director)
Biotechnology company developing safe and effective oral formulations of therapies traditionally limited to injections using ionic liquid technology
BiotechSaratoga, US
Mitragotri Mitragotri(Executive Officer, Director)Ravi Srinivasan(Executive Officer, Director)
BiotechSeattle, US
Peter Kolchinsky(Director)Charles Richardson(Senior Vice President, Technical Operations)Mark McDade(Director)Terry Gould(Director)Adam K. Simpson(President and Chief Executive Officer)Eric Moessinger(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 5
IPOs and acquisitions across the tracked portfolioFate TherapeuticsNASDAQ: FATEKymera TherapeuticsNASDAQ: KYMRMacrogenics IncNASDAQ: MGNXOmada HealthNASDAQ: OMDAQ32 BioNASDAQ: QTTB
Portfolio news
latest coverage across their companiesAdvanCell · intelligence360.news · Aug 4, 2026
NextPoint Therapeutics · nature.com · Jul 22, 2026
Attovia Therapeutics · medicaldialogues.in · Jul 19, 2026
Omada Health · investing.com · Jul 17, 2026
Mirador Therapeutics · biospace.com · Jul 17, 2026
Trial Library · zeebiz.com · Jul 16, 2026
Recodetx · geekwire.com · Jul 13, 2026
Atalanta · castleplacement.com · Jul 9, 2026
Frequently asked questions
- What stage does Sanofi Ventures invest at?
- Sanofi Ventures invests at the Seed, Series A, Series B, Growth, Late Stage stages.
- What is Sanofi Ventures's typical check size?
- Sanofi Ventures typically writes checks of $5M.
- What sectors does Sanofi Ventures focus on?
- Sanofi Ventures focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Sanofi Ventures located?
- Sanofi Ventures is headquartered in Cambridge, US.
- Does Sanofi Ventures lead rounds?
- Yes, Sanofi Ventures leads investment rounds.
Images
Co-investors · 39
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
RA Capital invests in public and private healthcare and life science companies developing pharmaceuticals, medical devices, and diagnostic tools. The firm operates as a crossover fund across multiple investment stages.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
SV Health Investors is a healthcare-focused private equity and venture capital investment platform managing specialized and diversified funds across biotechnology, healthcare growth equity, and medtech.
F-Prime Capital Partners is a venture capital firm whose team of scientists, engineers, physicians, operators, and investors supports companies in scaling and accelerating growth.
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
Dolby Family Ventures is an investment firm focused on life sciences, backing companies across precision neuroscience and life sciences platforms.
McKesson Ventures is the corporate venture arm of McKesson, one of the largest healthcare companies in the world, investing in software and services companies for the healthcare and pharma industries.
Mission BioCapital provides early-stage capital and shared lab space to life science entrepreneurs, supporting companies from idea through clinic and exit.
▶27 more co-investors
Lux CapitalForbionThe Column GroupSofinnova VenturesYsios CapitalAdjuvant CapitalGV (Google Ventures)Khosla VenturesVersant VenturesAbingworthRoche Venture FundSemperVirens Venture CapitalPontifax Venture CapitalPureos BioventuresMC Healthcare VenturesVertex Ventures IsraelS32EQT Life SciencesNorthpond VenturesGrove VenturesKurma PartnersFrazier Healthcare PartnersAccess IndustriesRiverVest VentureFaberJDRF T1D FundClarus Ventures
Firms observed investing alongside Sanofi Ventures, from public investor directories. Shared companies are the overlap with Sanofi Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.